Myron Z. Holubiak

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cranford, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Alexander M. Donaldson, by Power of Attorney
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Myron Z. Holubiak

Form 4 holding Secretary, Director

CITIUS ONCOLOGY, INC.

Security class
Stock Option (Right to Buy)
Shares / value
1,500,000
Estimated value
$3,135,000
Report date
19 Sep 2025
Price
$2.09
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,500,000
Form 4 holding Secretary, Director

CITIUS ONCOLOGY, INC.

Security class
Stock Option (Right to Buy)
Shares / value
50,000
Estimated value
$104,500
Report date
19 Sep 2025
Price
$2.09
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
50,000
Form 4 holding Vice Chairman, Director

Citius Pharmaceuticals, Inc.

Security class
Warrant to Purchase Common Stock
Shares / value
22,344
Estimated value
Report date
08 Aug 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
129,450
Form 4 holding Director

ASSEMBLY BIOSCIENCES, INC.

Security class
Stock Option (right to buy)
Shares / value
15,000
Estimated value
Report date
20 May 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Vice Chairman, Director

Citius Pharmaceuticals, Inc.

Security class
Stock Option (Right to Purchase Common Stock)
Shares / value
1,067
Estimated value
Report date
08 Aug 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
26,667
Form 4 holding Vice Chairman, Director

Citius Pharmaceuticals, Inc.

Security class
Stock Option (Right to Purchase Common Stock)
Shares / value
400
Estimated value
Report date
08 Aug 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
10,000

Insider Reports Filed by Myron Z. Holubiak

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .